Nadano S - Search Results

1

[Tolerability of Definitive Chemoradiotherapy in Elderly Patients with Esophageal Cancer].

Hino K, Kajiwara T, Nishina T, Inoue T, Yoshimatsu M, Sakaguchi C, Nakasya A, Nishide N, Asagi A, Hasebe A, Terao T, Hori S, Nadano S, Hamamoto Y, Kataoka M, Tanimizu M. Hino K, et al. Among authors: nadano s. Gan To Kagaku Ryoho. 2020 Nov;47(11):1577-1581. Gan To Kagaku Ryoho. 2020. PMID: 33268731 Japanese.

2

Clinical Outcomes of S-1 Monotherapy and Modified FOLFIRINOX Therapy after Gemcitabine plus Nab-paclitaxel Therapy in Unresectable Pancreatic Cancer.

Hino K, Nishina T, Numata Y, Asagi A, Inoue T, Yoshimatsu M, Sakaguchi C, Nakasya A, Nishide N, Kajiwara T, Terao T, Nadano S, Marui K, Okujima Y, Kokubu M, Imamura Y, Kanemitsu K, Koizumi M, Kumagi T, Hiasa Y, Hyodo I. Hino K, et al. Among authors: nadano s. Intern Med. 2022;61(15):2255-2261. doi: 10.2169/internalmedicine.8736-21. Epub 2022 Aug 1. Intern Med. 2022. PMID: 35908959 Free PMC article.

3

[Gemcitabine plus S-1 combination therapy (GS therapy) for pancreatic cancer patients with high-grade hepatic metastasis].

Matsumoto T, Takeji S, Asagi A, Kajiwara T, Nishina T, Hori S, Ikeda Y, Nadano S, Iguchi H. Matsumoto T, et al. Among authors: nadano s. Nihon Shokakibyo Gakkai Zasshi. 2011 Dec;108(12):2003-9. Nihon Shokakibyo Gakkai Zasshi. 2011. PMID: 22139487 Japanese.

4

Maximum standardized uptake value in ¹⁸F-fluoro-2-deoxyglucose positron emission tomography is associated with advanced tumor factors in esophageal cancer.

Kajiwara T, Hiasa Y, Nishina T, Matsumoto T, Hori S, Nadano S, Iguchi H, Takeji S, Tsubouchi E, Ikeda Y, Onji M. Kajiwara T, et al. Among authors: nadano s. Mol Clin Oncol. 2014 Mar;2(2):313-321. doi: 10.3892/mco.2014.238. Epub 2014 Jan 7. Mol Clin Oncol. 2014. PMID: 24649354 Free PMC article.

5

Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.

Asagi A, Ohta K, Nasu J, Tanada M, Nadano S, Nishimura R, Teramoto N, Yamamoto K, Inoue T, Iguchi H. Asagi A, et al. Among authors: nadano s. Pancreas. 2013 Jan;42(1):11-9. doi: 10.1097/MPA.0b013e3182550d77. Pancreas. 2013. PMID: 22699206 Free article.

6

Primary extranodal non-Hodgkin's lymphoma of the common bile duct manifesting as obstructive jaundice: report of a case.

Dote H, Ohta K, Nishimura R, Teramoto N, Asagi A, Nadano S, Hamada M, Yoshida I, Kobatake T, Nozaki I, Kubo Y, Tanada M, Kurita A, Takashima S. Dote H, et al. Among authors: nadano s. Surg Today. 2009;39(5):448-51. doi: 10.1007/s00595-008-3894-4. Epub 2009 Apr 30. Surg Today. 2009. PMID: 19408087

7

Brain metastasis from hepatocellular carcinoma treated with a cyber-knife.

Hiraoka A, Horiike N, Koizumi Y, Tazuya N, Ichiryu M, Nakahara H, Ochi H, Tanabe A, Doi H, Kodama A, Hasebe A, Ichikawa S, Miyamoto Y, Ninomiya T, Asagi A, Matsubara H, Nadano S, Nishizaki O, Umeda M. Hiraoka A, et al. Among authors: nadano s. Intern Med. 2008;47(22):1993-6. doi: 10.2169/internalmedicine.47.1373. Epub 2008 Nov 17. Intern Med. 2008. PMID: 19015615 Free article.

8

Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial.

Kudo M, Okusaka T, Motomura K, Ohno I, Morimoto M, Seo S, Wada Y, Sato S, Yamashita T, Furukawa M, Aramaki T, Nadano S, Ohkawa K, Fujii H, Kudo T, Furuse J, Takai H, Homma G, Yoshikawa R, Zhu AX. Kudo M, et al. Among authors: nadano s. J Gastroenterol. 2020 Jun;55(6):627-639. doi: 10.1007/s00535-020-01668-w. Epub 2020 Feb 27. J Gastroenterol. 2020. PMID: 32107609 Free PMC article. Clinical Trial.

9

Des-gamma-carboxy prothrombin identified by P-11 and P-16 antibodies reflects prognosis for patients with hepatocellular carcinoma.

Takeji S, Hirooka M, Koizumi Y, Tokumoto Y, Abe M, Ikeda Y, Nadano S, Hiasa Y, Onji M. Takeji S, et al. Among authors: nadano s. J Gastroenterol Hepatol. 2013 Apr;28(4):671-7. doi: 10.1111/jgh.12076. J Gastroenterol Hepatol. 2013. PMID: 23215762

10

Characteristics of geographic distributions and route of infection for hepatitis B virus genotype D in Ehime area in western Japan.

Matsuura K, Michitaka K, Yamauchi K, Nadano S, Okada S, Matsuura B, Hiasa Y, Horiike N, Onji M. Matsuura K, et al. Among authors: nadano s. Hepatol Res. 2007 Apr;37(4):255-62. doi: 10.1111/j.1872-034X.2007.00043.x. Hepatol Res. 2007. PMID: 17397513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page